| NOBEL Pharma Schweiz AG - Sitagliptin Metformin NOBEL 50 mg/1000 mg, Filmtabletten | | 68967 | | 03 | | Sitagliptin Metformin NOBEL 50 mg/1000 mg | | Filmtabletten | | A10BD07 | | Metformin and Sitagliptin | | 28.12.2023 | | |
| | Composition | | sitagliptinum 50 mg ut sitagliptini hydrochloridum monohydricum 56.69 mg, metformini hydrochloridum 1000 mg, povidonum K 30, cellulosum microcristallinum, crospovidonum, natrii stearylis fumaras, natrium 1.531 mg, Überzug: poly(alcohol vinylicus), E 171, macrogolum 3350, talcum, E 172 (rubrum), E 172 (nigrum), pro compresso obducto. | | Packungsbestandteile | | Coated tablets | | | | Active Agent | Dose |
|---|
| Metformin Hydrochloride | 1000 mg | | Sitagliptine | 50 mg |
| | | | Inactive agents | Dose | additional_information |
|---|
| (Nigrum) | | | | (Rubrum) | | | | Cellulosum Microcristallinum | | | | Crospovidonum | | | | E 171 | | color. | | E 172 | | color. | | Macrogol | 3350 | | | Natrii Stearylis Fumaras | | | | Sodium | 1.531 mg | | | Poly(Alcohol Vinylicus) | | Überzug | | Povidonum K | 30 | | | Pro Compresso Obducto | | | | Talcum | | |
|
| | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 005 | 56 | PR | PR | B | | No | | 006 | 4 x 49 | PR | PR | B | | No |
|
|
